ClinicalTrials.gg
CompletedNCT02352909Updated Sep 8, 2016

A Controlled Trial on Recreational Runners With Patellofemoral Pain

An interventional study of Education and Exercise program in Patellofemoral Pain (PFPS), sponsored by Laval University. Completed at 1 site in Canada. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2016-09-08.

Sponsored by Laval University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
69
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

From a rehabilitation point of view, while several approaches exist to retrain runners with PFPS, it is not clear which one is most effective, or why. The goals of this randomised-controlled trial are: 1) to compare the effectiveness of three rehabilitation programs on pain and functional limitations of runners with PFPS and 2) to explain why the programs are effective or not based on laboratory analyses. After baseline evaluation, runners will be randomly assigned to one of three treatment groups, each with a specific 8-week rehabilitation program aimed at addressing the efficiency of a specific type of retraining. These groups are: 1) Control; 2) muscle recruitment; 3) reducing knee loading during running.

The investigators hypothesis is that the intervention targeting a reduction in knee loading will be significantly more effective in reducing symptoms and improving function of runners with patellofemoral pain syndrome.

Read the detailed description

Hypothesis will be tested using symptoms and functional status questionnaires. In addition, mechanistic analyses will be conducted using a running assessment using an instrumented treadmill and kinematics analyses.

02

Conditions studied

  • Patellofemoral Pain (PFPS)
03

In context

Patellofemoral Pain Syndrome

299 studies on the registry are indexed under Patellofemoral Pain Syndrome; 74 are open to participants now.

This study's enrollment of 69 is above the median of 46 across 246 interventional studies indexed under Patellofemoral Pain Syndrome.

Browse Patellofemoral Pain Syndrome studies →

Lead sponsor

Laval University is the lead sponsor of 380 studies on the registry; 70 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Running mileage at least 15km
  • Symptoms since at least 3 months
  • Pain level at least 3/10 during running and 3 activities among: kneeling, squatting, stairs and resisted knee extension
  • Score lower than 85/100 on the KOS-ADLS

Exclusion criteria

Exclusion Criteria:

  • History of knee surgery or patellar dislocation
  • Pain believed to originate either from meniscus or from patellar tendon
  • Pain following an acute trauma
  • Concurrent lower limb injuries
  • History of neurological, inflammatory, rheumatoid disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
69 participants (actual)

Study arms

  • Active comparator
    Control

    Education will be given on how to modify running training to encourage improvement of symptoms.

    Other: Education

  • Experimental
    Muscle recruitment

    Subjects will receive an additional exercise program targeting non task-specific strengthening and motor control exercises of the lower limb.

    Other: Education · Other: Exercise program

  • Experimental
    Reduction of knee loading

    Subjects will receive additional personalized advice on how to modify running gait in order to reduce mechanical loads at the knee (gait retraining).

    Other: Education · Other: Gait retraining

Interventions

  • OtherEducation

    Education on running training modifications depending on symptoms (decrease running speed, spread running volume throughout the week, run/walk intervals, avoid downhill and stairs running). Education about symptoms will also be provided.

  • OtherExercise program

    A home-based program including strengthening and motor control exercises will be prescribed. The program will include 4 different phases of 2 weeks.

  • OtherGait retraining

    Running gait will be modified to reduce knee loading while running (step frequency, impact, foot strike pattern).

06

What researchers measure

Primary outcomes

  1. Changes in symptoms and function using a self-reported questionnaire, the Activities of Daily Living Scale of the Knee Outcome Survey (KOS-ADLS)

    A validated self-reported questionnaire (found to have the best psychometric properties in this population by a systematic review; Esculier et al., Disabil Rehabil 2013;35(26):2181-90) will be used to assess the severity of symptoms and functional limitations during the activities of daily living because of knee impairment. Changes in scores to this questionnaire will allow to compare the efficacy of rehabilitation protocols.

    Time frame: After 4 weeks and 8 weeks of rehabilitation; 3 months after the end of the rehabilitation program

Secondary outcomes

  1. Changes in pain scores using Visual analog scales (VAS)

    Visual analog scales will be used to assess levels of usual pain, worst pain and pain during running. Changes in scores to these scales will allow to compare the efficacy of rehabilitation protocols. These pain scales have been validated in this population.

    Time frame: After 4 weeks and 8 weeks of rehabilitation; 3 months after the end of the rehabilitation program

  2. Global rating of change (GRC)

    Self-reported outcome used to monitor perception of improvement or worsening of the condition following the intervention.

    Time frame: After the intervention (8 weeks)

  3. Changes in the vertical loading rate of ground reaction forces during treadmill running

    Vertical ground reaction forces and vertical loading rate during running on a Bertec instrumented treadmill. The average and instantaneous rise in vertical ground reaction forces will be considered between initial contact and initial peak in vertical forces. Data will be collected during running between 8-10km/h on a Bertec instrumented treadmill.

    Time frame: Baseline and after the intervention (8 weeks)

  4. Changes in ankle, knee, hip and pelvis kinematics during the stance phase of running

    Analysis of 3-dimensions motion of the lower limbs during running using VICON cameras. Peak angles and angular excursions will be assessed.

    Time frame: Baseline and after the intervention (8 weeks)

  5. Changes in patellofemoral joint load during the stance phase of running

    Using inverse dynamics, patellofemoral joint load during the stance phase of running will be estimated by combining kinematics data with force plates data.

    Time frame: Baseline and after the intervention (8 weeks)

  6. Changes in lower limb muscle strength

    Maximum isometric strength testing of the knee extensors and hip abductors, extensors and external rotators will be assessed using a handheld dynamometer with standard procedures.

    Time frame: Baseline and after the intervention (8 weeks)

07

Study locations

1 site
  • Centre for Interdisciplinary Research in Rehabilitation and Social Integration
    Québec, Quebec G1M 2S8, Canada
08

References and documents

Publications

  • Esculier JF, Bouyer LJ, Dubois B, Fremont P, Moore L, McFadyen B, Roy JS. Is combining gait retraining or an exercise programme with education better than education alone in treating runners with patellofemoral pain?A randomised clinical trial. Br J Sports Med. 2018 May;52(10):659-666. doi: 10.1136/bjsports-2016-096988. Epub 2017 May 5. PubMed 28476901 ↗
  • Esculier JF, Bouyer LJ, Dubois B, Fremont P, Moore L, Roy JS. Effects of rehabilitation approaches for runners with patellofemoral pain: protocol of a randomised clinical trial addressing specific underlying mechanisms. BMC Musculoskelet Disord. 2016 Jan 6;17:5. doi: 10.1186/s12891-015-0859-9. PubMed 26738470 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2014, a primary completion of May 2016 and a completion of May 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2014
First posted
Feb 2, 2015
Start
Jul 2014
Primary completionActual
May 2016
CompletionActual
May 2016
Last update
Sep 8, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02352909
Lead sponsor
Laval University
Responsible party
Sponsor
First posted
Feb 2, 2015
Start date
Jul 2014
Primary completion
May 2016
Completion
May 2016
Last update
Sep 8, 2016

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion